Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
177lu-psma-r2 (1 trial)
docetaxel (taxotere) (1 trial)
enzalutamide (xtandi) (1 trial)
lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (1 trial)
Prostatic Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (4 total)